--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--
--2023/Q20.000 / 0.000--
--2023/Q10.000 / 0.000--
--2022/Q40.000 / 0.000--
--------
--------
US Stock MarketDetailed Quotes
GPCR Structure Therapeutics
- 48.170
- -3.470-6.72%
Close Jun 14 16:00 ET
- 50.740
- +2.570+5.34%
Post 19:57 ET
2.68BMarket Cap-22992P/E (TTM)
52.140High46.600Low1.35MVolume52.140Open51.640Pre Close65.39MTurnover3.52%Turnover RatioLossP/E (Static)55.69MShares75.01752wk High6.24P/B1.85BFloat Cap25.57052wk Low--Dividend TTM38.40MShs Float75.017Historical High--Div YieldTTM10.73%Amplitude20.800Historical Low48.345Avg Price1Lot Size
Structure Therapeutics Key Stats
Structure Therapeutics Earnings Date
Currency: USD
Period
Q1 FY2024 Earnings
--
Revenue(YoY)
0.00
0.00%EPS(YoY)
-0.57
+24.00%Analyst Rating
Jun 13, 2024
Structure Therapeutics Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 7 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Structure Therapeutics Earnings Reports
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
